Natasha Honore
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 25, 2025
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 30, 2023
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 15, 2023
Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report.
Journal: Frontiers in oncology
Published: January 13, 2023
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact.
Journal: Cancers
Published: September 27, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026